CIK 0001108205 · Non-accelerated filer<br>Smaller reporting company
CURIS INC
Sign in to watch- Ticker
- CRIS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 043505116
- Phone
- 617-503-6500
- Business address
- 128 SPRING STREET, BUILDING C, SUITE 500, LEXINGTON, MA, 02421
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2007-06-06 | PASSERI DANIEL R CEO and Director | Grant or award · Qualified stock option (right to buy) | +60,836 | 60,836 | ||
| 2007-06-06 | PASSERI DANIEL R CEO and Director | Grant or award · Non-qualified stock option (right to buy) | +189,164 | 189,164 | ||
| 2007-06-06 | PASSERI DANIEL R CEO and Director | Grant or award · Qualified stock option (right to buy) | +71,942 | 71,942 | ||
| 2007-06-06 | PASSERI DANIEL R CEO and Director | Grant or award · Non-qualified stock option (right to buy) | +178,058 | 178,058 |
Page 29 of 29 · 564 trades